相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response
Tristan Rupp et al.
TRANSLATIONAL ONCOLOGY (2022)
Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models
Tristan Rupp et al.
TRANSLATIONAL ONCOLOGY (2021)
Role of NRF2 in Lung Cancer
Miriam Sanchez-Ortega et al.
CELLS (2021)
Prognostic Impact of Sphingosine Kinase 1 in Nonsmall Cell Lung Cancer
Nozomu Motono et al.
CLINICAL PATHOLOGY (2021)
Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases
Bisera Stepanovska et al.
PHARMACOLOGICAL RESEARCH (2020)
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
Stephanie Kourakis et al.
PHARMACEUTICALS (2020)
The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives
Wenjun Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer
Jiangang Zhao et al.
FRONTIERS IN ONCOLOGY (2020)
Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma
Xiran He et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Dimethyl fumarate, a two-edged drug: Current status and future directions
Nathaniel Edward Bennett Saidu et al.
MEDICINAL RESEARCH REVIEWS (2019)
Fingolimod sensitizes EGFR wild-type non-small cell lung cancer cells to lapatinib or sorafenib and induces cell cycle arrest
Kohki Ota et al.
ONCOLOGY REPORTS (2019)
PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells
Laura L. Stafman et al.
PLOS ONE (2019)
ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation
Luciana Rodrigues Gomes et al.
CELL DEATH & DISEASE (2019)
Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine
Mariam Gachechiladze et al.
ONCOLOGY LETTERS (2019)
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
Shang-Hung Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cisplatin decreases cyclin D2 expression via upregulating miR-93 to inhibit lung adenocarcinoma cell growth
Ning Xie et al.
MOLECULAR MEDICINE REPORTS (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
David P. Hill et al.
BMC CANCER (2019)
Fingolimod augments Pemetrexed killing of non-small cell lung cancer and overcomes resistance to ERBB inhibition
Laurence Booth et al.
CANCER BIOLOGY & THERAPY (2019)
The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer
Styliani Melissaridou et al.
CANCER CELL INTERNATIONAL (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Treatment of multiple sclerosis - success from bench to bedside
Mar Tintore et al.
NATURE REVIEWS NEUROLOGY (2019)
Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells
Yang Li et al.
ONCOLOGY REPORTS (2018)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non-tumorigenic cells
Nathaniel Edward Bennett Saidu et al.
Oncotarget (2018)
FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer
Kelly M. Kreitzburg et al.
CANCER LETTERS (2018)
The role of sphingosine-1-phosphate in inflammation and cancer progression
Masayuki Nagahashi et al.
CANCER SCIENCE (2018)
Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study
Min Kyoung Kim et al.
BMC CANCER (2018)
Dimethyl Fumarate Controls the NRF2/DJ-1 Axis in Cancer Cells: Therapeutic Applications
Nathaniel Edward Bennett Saidu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling
Nico Jacobi et al.
ONCOTARGET (2017)
Low Frequency Magnetic Fields Induce Autophagy-associated Cell Death in Lung Cancer through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway
Yujun Xu et al.
SCIENTIFIC REPORTS (2017)
Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
Sabira Mohammed et al.
FRONTIERS IN IMMUNOLOGY (2017)
Dimethyl Fumarate Inhibits the Nuclear Factor B Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein
Irida Kastrati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting F-κB
Jan P. Nicolay et al.
BLOOD (2016)
PD-1/PD-L1 expression in non-small-cell lung cancer and its correlation with EGFR/KRAS mutations
Mei Ji et al.
CANCER BIOLOGY & THERAPY (2016)
FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model
Cecile Gstalder et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Cisplatin resistance and opportunities for precision medicine
Lauren Amable
PHARMACOLOGICAL RESEARCH (2016)
Targeting sphingosine-1-phosphate signaling in lung diseases
David L. Ebenezer et al.
PHARMACOLOGY & THERAPEUTICS (2016)
The emerging role of FTY720 (Fingolimod) in cancer treatment
Christopher White et al.
ONCOTARGET (2016)
Tenascin-C Orchestrates Glioblastoma Angiogenesis by Modulation of Pro- and Anti-angiogenic Signaling
Tristan Rupp et al.
CELL REPORTS (2016)
3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
Michele Zanoni et al.
SCIENTIFIC REPORTS (2016)
Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasound
Yao Chen et al.
BMC CANCER (2015)
Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway
Xin Xie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis
Ciric To et al.
CARCINOGENESIS (2015)
The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod
Sathya Narayanan Patmanathan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt
Sushil C. Regmi et al.
PLOS ONE (2015)
Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer
Hao Liu et al.
ONCOTARGET (2015)
FTY720 enhances TRAIL-mediated apoptosis by up-regulating DR5 and down-regulating Mcl-1 in cancer cells
Seon Min Woo et al.
ONCOTARGET (2015)
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview
Roberto Bomprezzi
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2015)
Experience with erlotinib in the treatment of non-small cell lung cancer
Lorenza Landi et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2015)
Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
Sixian Liang et al.
ONCOTARGET (2015)
Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro
Giulia Marvaso et al.
CANCER BIOLOGY & THERAPY (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients
Benoit Langlois et al.
ONCOTARGET (2014)
Molecular Pathology of Lung Cancer: Current Status and Future Directions
Mee Sook Roh
TUBERCULOSIS AND RESPIRATORY DISEASES (2014)
Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
Roberta Rosa et al.
CLINICAL CANCER RESEARCH (2013)
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
Sahar A. Saddoughi et al.
EMBO MOLECULAR MEDICINE (2013)
Erlotinib resistance in lung cancer: current progress and future perspectives
Joy Tang et al.
FRONTIERS IN PHARMACOLOGY (2013)
Radiation Therapy for Early Stage Lung Cancer
Bhupesh Parashar et al.
SEMINARS IN INTERVENTIONAL RADIOLOGY (2013)
Dimethyl fumarate - only an anti-psoriatic medication?
Markus Meissner et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2012)
Five-year survival does not equal cure in non-small cell lung cancer: A Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10-to 18-year survival
Matthew O. Hubbard et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
Andrea Cavazzoni et al.
MOLECULAR CANCER (2012)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Dimethylfumarate Inhibits Angiogenesis In Vitro and In Vivo: A Possible Role for Its Antipsoriatic Effect?
Melissa Garcia-Caballero et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Rapid Generation of In Vitro Multicellular Spheroids for the Study of Monoclonal Antibody Therapy
Yen T. Phung et al.
JOURNAL OF CANCER (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1
Dmitri Pchejetski et al.
CANCER RESEARCH (2010)
Combination of Dacarbazine and Dimethylfumarate Efficiently Reduces Melanoma Lymph Node Metastasis
Teresa Valero et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Sphingosine 1-phosphate and cancer
Nigel J. Pyne et al.
NATURE REVIEWS CANCER (2010)
The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1
Gerald Schmid et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
A translational view of the molecular pathogenesis of lung cancer
Mitsuo Sato et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Dimethylfumarate impairs melanoma growth and metastasis
Robert Loewe et al.
CANCER RESEARCH (2006)
Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization
K LaMontagne et al.
CANCER RESEARCH (2006)
Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma
JWY Ho et al.
MOLECULAR CANCER THERAPEUTICS (2005)
FDA drug approval summary:: Erlotinib (Tarceva®) tablets
MH Cohen et al.
ONCOLOGIST (2005)
Combination treatment with erlotinib and pertuzumab against human tumor xenografts is superior to monotherapy
T Friess et al.
CLINICAL CANCER RESEARCH (2005)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
